Beta-amyloid (Aβ) aggregation and neurometabolic changes are biomarkers for Alzheimer’s disease (AD) at early stage. But their underlying relationship in association with AD pathology is still not fully understood. In this study, we simultaneously acquired 3D high-resolution MRSI using SPICE and 18F-AV45-PET images on a PET-MR scanner. Concurrent changes in neurometabolite concentrations and Aβ deposition in healthy control, mild cognitive impairment, and AD groups were compared. An increase in myo-inositol and a decrease in N-acetylaspartate were found as dementia became more severe. Our findings may lay a foundation for further investigation of AD pathogenesis using multimodal metabolic imaging.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords